SGLT2 Inhibitor Empagliflozin Ameliorates Tubulointerstitial Fibrosis in DKD by Downregulating Renal Tubular PKM2
Cellular and Molecular Life Sciences（2025）
Key words
Diabetic kidney disease,Epithelial-to-mesenchymal transition,Pyruvate kinase M2,Sodium-glucose cotransporter 2 inhibition,Tubulointerstitial fibrosis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined